drugset / Trial / NCT07216560
First-in-human Study of 7MW4911 in GI Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is the first-in-human study of 7MW4911 in US patients, to investigate its prelimary safety and efficacy in patients with gastrointestinal cancers.
Timeline
- Start
- 2026-01-13
- Primary completion
- 2027-07
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 7MW4911 | Unknown | — | — |